Dermata Therapeutics logo
Dermata Therapeutics
DRMA | NASDAQ
Chart Builder DCF Calculator
$0.60
-$0.02 (-3.41%)
At close: Nov 16, 2026, 4:00 PM ET
$0.64
+$0.04 (+6.63%)
After-hours: Nov 16, 2026, 5:48 PM ET

Dermata Therapeutics Company Profile

Company profile explained

Company Profile

Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Key Executives

Name Position
Gerald T. Proehl Founder, President, Chief Executive Officer & Chairman
Kyri K. Van Hoose Senior Vice President & Chief Financial Officer
Christopher J. Nardo Senior Vice President & Chief Development Officer
David F. Hale Co-Founder & Lead Independent Director
Kyra Peckaitis Vice President of Marketing
Maria Bedoya Toro Munera Senior Vice President of Regulatory Affairs & Quality Assurance
Sean Proehl Associate General Counsel

Latest SEC Filings

Date Type Title
Oct 29, 2026 8-K Current Report
Oct 21, 2026 424B3 Filing
Oct 20, 2026 EFFECT Filing
Oct 09, 2026 S-3 Filing
Aug 18, 2026 4 Filing
Aug 18, 2026 4 Filing
Aug 17, 2026 25-NSE Filing
Aug 17, 2026 8-K Current Report
Aug 11, 2026 10-Q Quarterly Report
Aug 11, 2026 8-K Current Report
View All SEC Filings ➞
Dermata Therapeutics
Dermata Therapeutics logo
Country United States
IPO Date Aug 13, 2021
Industry Biotechnology
Sector Healthcare
Employees 9
CEO Gerald T. Proehl

Contact Details

3525 Del Mar Heights Road San Diego, California 92130 United States

Stock Details

Ticker Symbol DRMA
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001853816
CUSIP Number 249845504
ISIN Number US2498455045
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.